pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009.

Pharma 106

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 106

European Pharmaceutical Review

FEBRUARY 22, 2023

1,7 It may depend on the competition between 6 Li and 7 Li, present at much higher concentration, to be ionised. Characterization of natural wax esters by MALDI-TOF mass spectrometry, J Mass Spectrom , 2009, 44, 101–110. An overview, J Incl Phenom Macrocycl Chem , 2009, 65, 237-248. percent and 7.5= Tran A, Monreal IA, et al.

Electronics 89

Electronics Food Pharmaceutical Doctors 89

Clarify Health

MARCH 1, 2023

Baptist Health System (BHS), a clinically integrated network of five hospitals in San Antonio, Texas, entered the Medicare Acute Care Episodes (ACE) program in 2009 and implemented behavioral economics to incentivize clinician performance. million on orthopedic MS-DRGs.[1]

Physicians 52

Physicians Prescription Medicine Healthcare 52

Medico Reach

FEBRUARY 17, 2023

Employee Size: 485 employees Website URL: [link] 2009 saw the launch of MDLive. Due to the high benefits of telehealth technology , millions of virtual medical facilities compete with one another in the highly competitive field to expand their healthcare operations. MDLive Headquarters: Miramar, Florida Revenue: $100.0M

Doctors 40

Doctors Healthcare Healthcare Physicians 40

CloserIQ

OCTOBER 10, 2018

Founded 2009. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Salsify offers competitive benefits and a flexible vacation plan. Employees can expect to work hard, and the company is currently hiring in sales and customer success. 101-250 employees.

Sales 76

Sales Management Education Marketing 76

pharmaphorum

JANUARY 24, 2023

Over the last 25 years, the headcount in the medicines manufacturing sector has fallen by 7,000 and since 2009 production volumes have fallen by nearly a third (29%), suggesting “faltering attractiveness” of the UK for manufacturing.

Manufacturing 105

Manufacturing Medicine Government Pharmaceutical manufacturing 105

European Pharmaceutical Review

SEPTEMBER 14, 2023

Market uncertainty Rising operational costs, stiffening competition, ongoing patent expirations, evolving environmental and social governance requirements and increasing pressure on drug prices mean the industry will have to navigate thoughtfully to be successful amid this complicated mix of financial and strategic risks.

Manufacturing 81

Manufacturing Engineering Management Pharmaceutical 81

European Pharmaceutical Review

DECEMBER 22, 2022

competitive binding-MS for analysis of multiple PQAs and rapid HT N-glycan analysis using combined LC/MS. 2017 Aug 1;28(8):2009-2012. This need has led to advancements in HT mass spectrometry (MS) techniques, including: affinity-native protein A-MS for assessment of chain pairing and fragmentation without purification 7. 2021.102240.

Manufacturing 82

Manufacturing Engineering Leads Pharmaceutical 82

Evolve Your Success

MAY 16, 2023

I remember back in my pharmaceutical sales rep days and I’m talking as far as 2009 or 2010. How long have you been working in the opioid addiction space? I came on board a few years ago. Opioid addiction has been around for a while. I would see some primary care providers. They were giving opioids like the wind.

Medical sales 52

Medical sales Sales Medical Doctors 52

Evolve Your Success

DECEMBER 20, 2022

He began his career in instrument reprocessing as a frontline technician in 2009, and then served as an instrument database specialist. We’ll get into some of this, but I was in the hospital setting back in 2009. I started in 2009 and I was already tuned into social media like a lot of folks in my generation.

Medical sales 52

Medical sales Media Sales Medical sales reps 52

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

APRIL 6, 2023

The draft guidance, released on March 5, is open for comments until May 7, after which it will replace an earlier 2009 guidance for the industry. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

FDA 52

FDA Patients Food and Drug Administration Prospecting 52